Geopolitical disruptions impacting raw material and logistics
Management noted increasing geopolitical tensions may pressure OTF performance in generics.
medium · management_commentaryLaurus Labs Limited — Q4 FY26
Laurus Labs delivered a strong FY26 with revenue of ₹6,813 crore (+23% YoY) and EBITDA margin expansion of 670 bps to 26.8%, driven by a 38% surge in small molecule CDMO (₹1,896...
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Solvent price increases affecting margins
Q4 FY26 saw some impact; management expects to weather via mix and utilization.
low · analyst_questionConcentration risk in CDMO commercial products
Analyst raised concern; management stated three commercial APIs have long patent life and clear forecasts, but no granular disclosure.
medium · analyst_questionUncertainty in OLED and crop science revenue timing
Management deferred specifics on OLED collaboration and crop science ramp-up, indicating multi-quarter uncertainty.
low · analyst_question